Selected Abstracts
Dialysis, Chronic Renal Failure
Adequacy, prescription, urea kinetics
d 
Effects of different dialysis schedules on anemia and
hypertension
d
Long-term results of a dialytic schedule with increased frequency of HD
sessions
GI/Liver, Hepatitis
d
Peritoneal dialysis in 15 cirrhotic patients with chronic renal
failure: long term study
d
Gastric emptying in patients with ESRD, CAPD or hemodialysis
d
CPD using closed-system automated PD is effective in the treatment of
severe acute pancreatitis
CRF in Women
d
Patient-reported hemoperitoneum and its relation to
menstruation in women on PD: Results of a patient survey
Joint disease, beta-2 microglobulin
d
Peritoneal dialysis in patients with systemic lupus erythematosus: a
single-center experience
Psychiatric
d
Psychological adjustment to compliance, depression, and staff social
support: their relation to objective compliance in ESRD patients
Anemia/Erythropoietin/Iron
d
Total dose iron infusion: a time saving cost effective method of iron
replacement
d
Importance of iron saturation for erythropoietin responsiveness
in chronic peritoneal dialysis
d
Clinical experience with intraperitoneal EPO in adult patients on
peritoneal dialysis
d
Pharmacokinetics of IP EPO in CAPD patients following instillation
into a dry peritoneum
Bone disease/aluminum
d
Frequent relapse of secondary hyperparathyroidism after oral pulse
calcitriol administration in peritoneal dialysis patients
d
Magnesium and parathyroid hormone levels in peritoneal dialysis
patients
CRF and diabetes
d
Peripheral vascular disease in diabetic patients on PD
receiving EPO
CRF in infants and children
d
Improved dialysis dose by optimizing intraperitoneal volume
prescription thanks to intraperitoneal pressure measurements in
children
Nutrition
d
Orexigen and anorexigen plasma levels in peritoneal dialysis patients.
Their relationship with nutritional parameters.
d
CQI process decreases malnutrition in peritoneal dialysis
patients
Outcomes (Morbidity, Mortality)
d
An evaluation of the causes which lead to transfer from peritoneal
dialysis
d
Characteristics of long-term peritoneal dialysis patients
d
Post-transplant renovascular thrombosis is not more common in CAPD
recipients
PD catheters
d
Prevention of exit-site infection with hypertonic saline
d
Cost efficiency of temporary subcutaneous implantation of
peritoneal dialysis catheter
d
Effective titanium adapter disinfection for PD transfer set
change procedure
Complications of PD
d
Does a large dialysate volume (2.5 liters) increase hernia
formation in CAPD?
d
Can an elevated intraperitoneal pressure predict PD complications?
d
Peritoneography and peritoneal computerized tomography in CAPD
patients
PET testing
d
Relationship between glucose and calcium in the glycation of collagen
matrix when exposed to peritoneal fluids
Physiology
d
Water channel AQP1, 3, 4 in the human peritoneum and peritoneal
dialysate
d
Effect of posture on intraperitoneal pressure (Pip) and
peritoneal permeability in children
d
Differences in fluid transport between diabetic and non-diabetic
patients at the onset of CAPD
PD procedure: tips
d
Temporary stoppage of PD when laparoscopic procedures are
performed on patients undergoing CAPD/CCPD: a change in policy
Peritonitis and exit-site infection
d
Is the treatment of beta-lactam-sensitive infections without
vancomycin possible?
d
Teicoplanin-cefotaxime vs. vancomycin-tobramycin as initial
treatment of peritonitis in peritoneal dialysis
d
The relationship between exit-site infection and peritonitis
d
Reduction of infectious complications by temporary subcutaneous
implantation of PD catheters
d
Management of Pseudomonal exit-site infection
d
Accuracy of a polyclonal vancomycin immunoassay in peritoneal dialysis
d
Well-water related peritonitis
d
The effect of aminoglycoside use on residual renal function in
PD patients
d
Reduced incidence of peritonitis by utilizing "flush before
fill" in APD
d
2-Gram intraperitoneal cefazolin for the treatment of
peritonitis
d
Outcomes of gram-positive peritonitis and gram-negative
peritonitis
Chronic PD regimens, adequacy, modeling
d
Measuring compliance with prescribed exchanges in PD patients
d
Dialysate/plasma urea and creatinine in 24 hour clearance studies in
CAPD, CCPD, and NPD
d
Patient tolerance of 2, 2.5, and 3 L PD exchange volumes
d
Adequate dialysis is achievable among almost all anuric peritoneal
dialysis patients
Lipids
d
Transient thrombocytopenia in peritoneal dialysis patients associated
with niacin
d
The effect of change of renal replacement therapy on plasma
lipoprotein (a) [Lp(a)] concentration
Progression
d
The study of ACE converting enzyme polymorphism on CAPD patients
Use back arrow on your browser to go back to HDCN home page (faster)
or click on the arrow.